-
Theriva™ Biologics Announces Upcoming Presentation of Data from VCN-01 Retinoblastoma Phase 1 Clinical Trial at APAO 2026
03 Feb 2026 13:00 GMT
… Oncolytic Adenovirus VCN-01 Trial in Retinoblastoma
Session: … Drug designation and Rare Pediatric Diseases designation from the FDA for the treatment … of VCN-01 and topotecan providing an exciting … results in future trials for the treatment of retinoblastoma …
-
CDSCO Clears Over 100 rDNA Drugs and Biologics Between 2020-25, Boosting Access to Advanced Therapies
23 Jan 2026 13:52 GMT
… and advanced vaccines, revolutionizing treatment for many … Pharmaceuticals Ltd. received approval for the manufacture of Pertuzumab (drug … 47;s Epygen Biotech Private Limited
21 … topotecan, or pegylated liposomal doxorubicin is indicated for the treatment …
-
Actuate Therapeutics Announces Positive Patient Outcomes from Phase 1 Trial in Difficult-to-Treat Refractory Pediatric Cancers
06 Jan 2026 13:45 GMT
… plus cyclophosphamide/topotecan
Data support advancing clinical … 10) on treatment. Long term treatment with elraglusib monotherapy … studies, early clinical trials and sub-group … competition from other biotechnology and pharmaceutical companies; our ability …
-
<![CDATA[FDA Grants Breakthrough Therapy Status to JSKN003 for Advanced Ovarian Cancer]]>
22 Dec 2025 16:55 GMT
… targeting antibody-drug conjugate (ADC), for the treatment of adult … liposomal doxorubicin, paclitaxel, or topotecan) with or without bevacizumab, … trial in China (JSKN003-306; NCT06751485) and has received FDA … findings from two clinical trials. J Clin Oncol. …
-
Patient deaths put Merck, Daiichi’s ADC trial on partial hold
20 Dec 2025 01:48 GMT
… actions.” Trial enrollees will be able to continue treatment, … found success with their medicines Enhertu and Datroway, … either topotecan, lurbinectedin or amrubicin.
Expectations for the drug … lung cancer. The FDA granted breakthrough therapy designation …
-
A Multi-Country Study of the Clinical Course of Extensive-Stage Small Cell Lung Cancer: A Six-Study Analysis of Real-World Treatment Patterns and Outcomes
19 Dec 2025 14:01 GMT
… clinical trial or treatment with an investigational study drug, … any other platinum regimens; topotecan; lurbinectedin; taxane; cyclophosphamide, … Spanish Agency for Medicines and Medical Devices (ClinicalTrials. … CASPIAN9 and IMpower13310 trials which led to …
-
Lung Cancer Trial to Proceed After FDA Releases Hold on Merck, Daiichi’s ADC
19 Dec 2025 13:49 GMT
… with the European Medicines Agency toward lifting … These strategies include “stricter trial enrollment eligibility criteria” and … topotecan, amrubicin and lurbinectedin.
In a joint statement to Fierce Biotech … the FDA did not identify issues with the drug’s …
-
<![CDATA[Self-driven electrical triggering system enhances drug delivery in bladder cancer therapy]]>
04 Dec 2025 06:43 GMT
… bladder cancer treatment has always been poor drug penetration into … (topotecan) and Camptosar (irinotecan), have been developed by pharmaceutical companies … the Sichuan Academy of Medical Sciences and Sichuan … can advance to human trials. They also plan …
-
<![CDATA[FDA Grants Full Approval to Tarlatamab in Small Cell Lung Cancer]]>
20 Nov 2025 10:47 GMT
… phase 3 DeLLphi-304 trial (NCT05740566), in which … results with the treatment in other trials. Fewer patients … of lurbinectedin (n = 47), topotecan (n = 185), or amrubicin … ;www.fda.gov/drugs/;resources-information-approved-drugs/fda-grants- …
-
<![CDATA[Tarlatamab Earns Traditional FDA Approval in ES-SCLC]]>
19 Nov 2025 22:25 GMT
… phase 3 DeLLphi-304 trial (NCT05740566), in which … choice of chemotherapy with topotecan, lurbinectedin, or amrubicin. … unacceptable toxicity.
The FDA previously granted accelerated approval … 2 DELLphi-301 trial (NCT05060016).
FDA grants traditional approval …
About
© 1995-2026